Concepedia

Philippe Hasgall

PH

5

Publications

269

Citations

5

H-Index

2007

Active since

Affiliations

University of Zurich(Current)

Swiss Integrative Center for Human Health

Smith & Nephew (United States)

Sulzer (Switzerland)

Johnson & Johnson (United States)

Philippe Hasgall is an author at University of Zurich specializing in toxicology, medical devices, and medicine.

Top concepts

Publications per year

2007–2021

5

Publications

5

The Peptidyl Prolyl <i>cis/trans</i> Isomerase FKBP38 Determines Hypoxia-Inducible Transcription Factor Prolyl-4-Hydroxylase PHD2 Protein Stability

Sandra Barth, Jutta Nesper, Philippe Hasgall et al. · Molecular and Cellular Biology · 2007 · 104 citations · Full text

Hypoxia-inducible Factor Prolyl-4-hydroxylase PHD2 Protein Abundance Depends on Integral Membrane Anchoring of FKBP38

Sandra Barth, Frank Edlich, Utta Berchner‐Pfannschmidt et al. · Journal of Biological Chemistry · 2009 · 72 citations · Full text

A hazard evaluation of the reproductive/developmental toxicity of cobalt in medical devices

Andrew D. Monnot, Michael Kovochich, Suren B. Bandara et al. · Regulatory Toxicology and Pharmacology · 2021 · 37 citations · Full text

, , +21

Carcinogenic hazard assessment of cobalt-containing alloys in medical devices: Review of in vivo studies

Michael Kovochich, Andrew D. Monnot, Daniel G. Kougias et al. · Regulatory Toxicology and Pharmacology · 2021 · 34 citations · Full text

, , +15

The Putative RNA Helicase HELZ Promotes Cell Proliferation, Translation Initiation and Ribosomal Protein S6 Phosphorylation

Philippe Hasgall, David Hoogewijs, Marius B. Faza et al. · PLoS ONE · 2011 · 22 citations · Full text

Rows per page

1–5 of 5